Efficacy of platelet-rich plasma injection in combination with tranexamic acid compared with tranexamic acid injection alone inthe treatment of macular amyloidosis
Phase 1
Recruiting
- Conditions
- Macular amyloidosis.Other amyloidosisE85.8
- Registration Number
- IRCT20220808055641N4
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Clinical diagnosis of macular amyloidosis
Age above 18 years old
Exclusion Criteria
Pregnancy
Breastfeeding
Coagulation disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of macular amyloidosis. Timepoint: The beginning of the study and 1 month after the start of the study and 3 months after the start of the study. Method of measurement: sonography;visioface;biometery;cutometery,physician global assessment score;patient global assessment score.
- Secondary Outcome Measures
Name Time Method